MUSTANG BIO, INC.

MBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations
190
SEC Filings

Business Summary

PARTI OVERVIEW Mustang Bio,Inc. (Mustang, we, us, our or the Company) is a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs into potential cures for difficult-to-treat cancers. We aim to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. Our pipeline is currently focused on n...

Next Earnings

Q2 FY2026 — expected 2026-07-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMBIOdiscussed_in_filing Cybersecurity
topic_mentionMBIOdiscussed_in_filing Trusted Computing
topic_mentionMBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionMBIOdiscussed_in_filing Capital Expenditure
topic_mentionMBIOdiscussed_in_filing Regulation
topic_mentionMBIOdiscussed_in_filing Healthcare & Bio
topic_mentionMBIOdiscussed_in_filing Cybersecurity
topic_mentionMBIOdiscussed_in_filing Trusted Computing
topic_mentionMBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionMBIOdiscussed_in_filing Capital Expenditure
topic_mentionMBIOdiscussed_in_filing Regulation
topic_mentionMBIOdiscussed_in_filing Healthcare & Bio
topic_mentionMBIOdiscussed_in_filing Cybersecurity
topic_mentionMBIOdiscussed_in_filing Trusted Computing
topic_mentionMBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionMBIOdiscussed_in_filing Capital Expenditure
topic_mentionMBIOdiscussed_in_filing Regulation
topic_mentionMBIOdiscussed_in_filing Healthcare & Bio
topic_mentionMBIOdiscussed_in_filing Cybersecurity
topic_mentionMBIOdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001104659-26-032063EDGAR78K words
2025-03-282024-12-310001558370-25-003913EDGAR
2024-03-112023-12-310001558370-24-002899EDGAR
2023-03-302022-12-310001558370-23-004979EDGAR
2022-03-232021-12-310001558370-22-004143EDGAR
2021-03-242020-12-310001558370-21-003433EDGAR
2020-03-162019-12-310001104659-20-034130EDGAR
2019-03-182018-12-310001144204-19-014624EDGAR
2018-03-292017-12-310001144204-18-017988EDGAR
2017-03-312016-12-310001144204-17-017831EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001104659-25-108468EDGAR45K words
2025-08-082025-06-300001558370-25-010920EDGAR
2025-05-142025-03-310001558370-25-007736EDGAR
2024-11-082024-09-300001558370-24-015048EDGAR
2024-08-132024-06-300001558370-24-012051EDGAR
2024-05-152024-03-310001558370-24-008283EDGAR
2023-11-142023-09-300001558370-23-019010EDGAR
2023-08-142023-06-300001558370-23-014832EDGAR
2023-05-122023-03-310001558370-23-009592EDGAR
2022-11-142022-09-300001558370-22-017819EDGAR
2022-08-112022-06-300001558370-22-013261EDGAR
2022-05-122022-03-310001558370-22-008525EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-12-230001104659-25-124189EDGAR1K words
2025-07-090001104659-25-066520EDGAR
2025-03-050001104659-25-020900EDGAR
2025-02-270001104659-25-018299EDGAR
2025-02-210001104659-25-016145EDGAR
2025-02-130001104659-25-013029EDGAR
2025-02-110001104659-25-011517EDGAR
2025-01-170001104659-25-004565EDGAR
2025-01-100001104659-25-002599EDGAR
2025-01-020001104659-25-000343EDGAR

190 total filings indexed. 158 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001680048
TickerMBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8e635e046a9c34ebad5a7e5c90cf68fefc09a672aa72b820aae968c6142ca2e9
parent: ba888b7634266c2aecf19aeaf0b92438e20ec79e44ecbaaa1d650b6120fc3429
content hash: d75801c89d25cafa9614e0cf31bf6a701ecfb04e3b60036f4863a80166f35c78
signed: 2026-04-13T04:46:11.022Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf